000 01541 a2200433 4500
005 20250512001028.0
264 0 _c19860424
008 198604s 0 0 eng d
022 _a0014-5793
024 7 _a10.1016/0014-5793(86)80327-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStriessnig, J
245 0 0 _aPurified calcium channels have three allosterically coupled drug receptors.
_h[electronic resource]
260 _bFEBS letters
_cMar 1986
300 _a204-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
650 0 4 _aAllosteric Regulation
650 0 4 _aAmines
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCalcium Channel Blockers
650 0 4 _aDihydropyridines
650 0 4 _aDiltiazem
_xpharmacology
650 0 4 _aGuinea Pigs
650 0 4 _aIon Channels
_xdrug effects
650 0 4 _aIsradipine
650 0 4 _aMuscles
_xultrastructure
650 0 4 _aNifedipine
_xanalogs & derivatives
650 0 4 _aOxadiazoles
_xmetabolism
650 0 4 _aPyridines
_xmetabolism
650 0 4 _aReceptors, Drug
_xmetabolism
650 0 4 _aVerapamil
_xanalogs & derivatives
700 1 _aGoll, A
700 1 _aMoosburger, K
700 1 _aGlossmann, H
773 0 _tFEBS letters
_gvol. 197
_gno. 1-2
_gp. 204-10
856 4 0 _uhttps://doi.org/10.1016/0014-5793(86)80327-1
_zAvailable from publisher's website
999 _c2425216
_d2425216